Emergent external ventricular drain placement in patients with Factor Xa Inhibitor-associated intracerebral hemorrhage after reversal with Andexanet Alfa
Abdalla A. Ammar,Aladine A. Elsamadicy,Mahmoud A. Ammar,Benjamin C. Reeves,Andrew B. Koo,Guido J. Falcone,David Y. Hwang,Nils Petersen,Jennifer A. Kim,Rachel Beekman,Morgan Prust,Jessica Magid-Bernstein,Julián N. Acosta,Ryan Herbert,Kevin N. Sheth,Charles C. Matouk,Emily J. Gilmore
DOI: https://doi.org/10.1016/j.clineuro.2023.107621
2023-02-10
Clinical Nephrology - Case Studies
Abstract:Background Andexanet alfa (AA), factor Xa-inhibitors (FXi) reversal agent, is given as a bolus followed by a 2-hour infusion. This long administration time can delay EVD placement in intracerebral hemorrhage (ICH) patients. We sought to evaluate the safety of EVD placement immediately post-AA bolus compared to post-AA infusion. Methods We conducted a retrospective study that included adult patients admitted with FXi-associated ICH who received AA and underwent EVD placement. Primary outcome was the occurrence of a new hemorrhage (tract, extra-axial, or intraventricular hemorrhage). Secondary outcomes included mortality, intensive care unit and hospital length of stay, and discharge modified Rankin Score. The primary safety outcome was documented thrombotic events. Results Twelve patients with FXi related ICH were included (EVD placement post-AA bolus, N=8; EVD placement post-AA infusion, N=4). Each arm included one patient with bilateral EVD placed. There was no difference in the incidence of new hemorrhages, with one post-AA bolus patient had small, focal, nonoperative extra-axial hemorrhage. Morbidity and mortality were higher in post-AA infusion patients (mRS, post-AA bolus, 4 [4-6] vs. post-AA infusion 6 [5-6], p=0.24 and post-AA bolus, 3 (37.5%) vs. post-AA infusion, 3 (75%), p=0.54, respectively). One patient in the post-AA bolus group had thrombotic event. There was no difference in hospital LOS (post-AA bolus, 19 days [12-26] vs. post-AA infusion, 14 days [9-22], p=0.55) and ICU LOS (post-AA bolus, 10 days [6-13] vs. post-AA infusion, 11 days [5-21], p=0.86). Conclusion We report no differences in the incidence of tract hemorrhage, extra-axial hemorrhage, or intraventricular hemorrhage post-AA bolus versus post-AA infusion. Larger prospective studies to validate these results are warranted.